Brought to you by 
Ascletis goes public on Hong Kong exchange raising $399mm
25 Oct 2018
Executive Summary
China-based Ascletis Pharma Inc. has raised HK$3.14bn ($399mm) its initial public offering of 224mm shares priced at HK$14 (the middle of its anticipated HK$12-16 range) on the Hong Kong exchange.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ascletis goes public on Hong Kong exchange raising $399mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice